Heron Therapeutics | HRTX - Ativo Circulante





Ativo Circulante Alterar Data
ALKERMES USD 1.36B 570.52M 2026-03
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amarin USD 626.02M 23.87M 2026-03
ANI Pharmaceuticals USD 747.08M 6.03M 2026-03
Anika Therapeutics USD 93.56M 9.8M 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
Eisai JPY 761.64B 79.24B 2026-03
Emergent BioSolutions USD 679.5M 41.3M 2023-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Ligand Pharmaceuticals USD 865.42M 33.14M 2026-03
Merck USD 35.02B 8.5B 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Omeros USD 69.65M 26.53M 2025-06
Pacira USD 514.96M 33.01M 2026-03
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 35.44B 3.29B 2026-06
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Veracyte USD 522.17M 33.8M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03